Ken Fisher Cytokinetics Inc Transaction History
Fisher Asset Management, LLC
- $227 Billion
- Q1 2025
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Cytokinetics Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 793,458 shares of CYTK stock, worth $28.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
793,458
Previous 616,492
28.71%
Holding current value
$28.5 Million
Previous $29 Million
9.97%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding CYTK
# of Institutions
399Shares Held
128MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$527 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$425 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$357 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$287 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$218 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.38B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...